AWILDA BELLE: Open Payments
NPI 1164756490 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,590 in 108 payments from 38 companies in 2025. Trend: 2023 $2,687 · 2024 $2,912 · 2025 $2,590
Food & beverage: $2,391Education: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $369 |
| Gilead Sciences, Inc. | 12 | $332 |
| E.R. Squibb & Sons, L.L.C. | 10 | $174 |
| GlaxoSmithKline, LLC. | 7 | $153 |
| Incyte Corporation | 6 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| PFIZER INC. | 6 | $133 |
| Rigel Pharmaceuticals, Inc. | 2 | $126 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| Lilly USA, LLC | 3 | $62 |
Products named: Trodelvy, IMBRUVICA, VENCLEXTA, OPDIVO, TAVALISSE, OJJAARA, IBRANCE, KISQALI.
Industry payments across FL — which companies pay providers there.
